至本医疗科技（上海）有限公司 OrigiMed
Overview
OrigiMed is a Shanghai-based genetic testing and precision medicine company that provides comprehensive genomic analysis and molecular diagnostics services for cancer and inherited disease detection. The company leverages advanced sequencing technologies to support clinical decision-making and personalized treatment planning for healthcare providers and patients.
More in Genetic Testing
Latest industry news
Vietnam Moves to Address Regulatory and Ethical Gaps in DNA Testing Deployment
2026-09-14 · Policy
Regeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Rare Disease Genomics
2026-09-13 · Product
Guardant Health's Expanded Liquid Biopsy Panel Earns FDA Clearance with 100x Footprint Growth
2026-09-12 · Product
Slovenia's GenePlanet Secures Strategic Investment from Lauxera in Unicorn-Backed Genomics Push
2026-09-11 · Funding
Company details
Category
🧬 Genetic Testing
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →